Hi Nele,

 

So what exactly is the IIV model you are testing? Showing code is probably 
clearest. A model with only diagonal IIV in CL/F and V/F may well be 
underparameterized.

What happened with the mixture?

 

Best regards,

Mats

 

Mats Karlsson, PhD

Professor of Pharmacometrics

Dept of Pharmaceutical Biosciences

Uppsala University

Box 591

751 24 Uppsala Sweden

phone: +46 18 4714105

fax: +46 18 471 4003

 

From: nele.pl...@nycomed.com [mailto:nele.pl...@nycomed.com] 
Sent: Thursday, April 16, 2009 9:12 AM
To: mats.karls...@farmbio.uu.se
Cc: nmusers@globomaxnm.com
Subject: RE: [NMusers] OMEGA BLOCK with mixture model?

 


Dear Mats, 

thank you, that is exactly what I am trying now (as I have IIV on central 
volume). I will now only include the diagonal elements of the omega matrix, and 
have included the correlation in the thetas as CL/F. 
Let's see how this works. 
One question out of curiosity: I know that in a one-compartment model, NONMEM 
would not be able to differentiate between IIV on volume or IIV on F1. But with 
more compartments, this should work, shouldn't it, even if I only have oral 
data? 

Best wishes 
Nele 
______________________________________________________________

Dr. Nele Plock
Pharmacometrics -- Modeling and Simulation

Nycomed GmbH
Byk-Gulden-Str. 2
D-78467 Konstanz, Germany

Fon: (+49) 7531 / 84 -  4759
Fax: (+49) 7531 / 84 - 94759

mailto: nele.pl...@nycomed.com
http://www.nycomed.com

County Court: Freiburg, Commercial Register HRB 701257
Chairman Supervisory Board: Charles Depasse
Management Board: Dr. Barthold Piening, Gilbert Rademacher, Dr. Anders Ullman





mats.karls...@farmbio.uu.se 

16.04.2009 09:05 


To

drmo...@pri-home.net, Nele Plock/DEKON/AP/alt...@altana-mail, 
nmusers@globomaxnm.com 


cc

        

Subject

RE: [NMusers] OMEGA BLOCK with mixture model?

 

                




Hi Diane, 
  
With oral data only I would normally model with BLOCK(2) on CL/F and V/F or a 
DIAG(3) on CL/F, V/F and relative F. The latter may have some advantages for 
diagnostics, covariate model building etc. Also, if the underlying model truly 
is a mixture model on F, it could be parsimonious, needing mixture only one 
parameter only. You can’t have IIV on CL, V and relF + off-diagonal elements 
without overparameterizing the model. However, although I have never tried it, 
I guess that a BLOCK(2) on CL and relative F could work, provided you have no 
ETA on V. If you also have an ETA on V all the problems you mention would be 
realized. I don’t know if Nele has IIV on V, but if so, she should definitely 
reduce IIV model size. With respect to the mixture model, maybe it is possible 
to reparameterize such that the mixture component only concerns one ETA. 
  
Best regards, 
Mats 
  
Mats Karlsson, PhD 
Professor of Pharmacometrics 
Dept of Pharmaceutical Biosciences 
Uppsala University 
Box 591 
751 24 Uppsala Sweden 
phone: +46 18 4714105 
fax: +46 18 471 4003 
  
From: Diane R Mould [mailto:drmo...@attglobal.net] 
Sent: Wednesday, April 15, 2009 6:16 PM
To: 'Mats Karlsson'; nele.pl...@nycomed.com; nmusers@globomaxnm.com
Subject: RE: [NMusers] OMEGA BLOCK with mixture model? 
  
Dear All 
  
I am not sure if this topic has been covered before or not, but as its related 
to the question below, I thought I would bring it up again. 
  
I have to wonder at the appropriateness of including the IIV term for F in an 
omega BLOCK structure in the first place?  I can certainly understand 
estimating relative bioavailability and even estimating the associated 
variability for F, although there are often estimatability issues for an IIV 
term for F, even with IV data to help estimate F (or at least using a reference 
value for F like one formulation or one occasion).   
  
However because with orally administered drugs, CL is really CL/F then there is 
an inherent correlation between CL and F.  With F and CL, this correlation is 
really in the THETA values so that if the model captures the correlation at the 
THETA level, ie allow for larger clearance with larger F (or vice versa), then 
the random effects for F and CL may be uncorrelated.  However, if the 
population model does not capture that correlation at the THETA level, then 
correlation will be captured via the random effects, possibly resulting in an 
over-parameterized OMEGA matrix.  As this latter situation seems to be very 
common (e.g. that the correlation between F and CL etc is picked up in the 
etas) then one might expect to see high condition numbers, zero gradients etc 
when IIV on F is added to the omega BLOCK structure. 
  
I would guess that as a rule, its probably more appropriate to keep the IIV 
term for F out of a BLOCK structure.  Can anybody comment on this? 
  
Best regards, 
Diane 
  

 

  _____  


From: owner-nmus...@globomaxnm.com [mailto:owner-nmus...@globomaxnm.com] On 
Behalf Of Mats Karlsson
Sent: Tuesday, April 14, 2009 2:08 PM
To: nele.pl...@nycomed.com; nmusers@globomaxnm.com
Subject: RE: [NMusers] OMEGA BLOCK with mixture model? 
  
Dear Nele, 
  
I think you may want to reconsider your model. If you have a negative 
correlation between CL and F1, it is likely to be related to high presystemic 
metabolism (first-pass) effect. If so, it seems strange to assume that the F1 
distribution would not change between the two subpopulations. I think you need 
to have separate CL as well as F1 for the two subpopulations. Thus I would have 
CL and F1 described by ETA(1) and ETA(2) for subpopulation 1 and CL and F1 
described by ETA(3) and ETA(4) for the second subpopulation.  If hepatic 
elimination is responsible for the correlation, it is probably more 
parsimonious to use a semi-mechanistic model with a hepatic compartment (with a 
single ETA for variation in metabolic activity). Two examples of 
implementations of a separate hepatic compartment are : 
Piotrovskij et al. Pharm Res. 1997 Feb;14(2):230-7. 
Gordi et al., Br J Clin Pharmacol. 2005 Feb;59(2):189-98 
  
Best regards, 
Mats 
  
  
Mats Karlsson, PhD 
Professor of Pharmacometrics 
Dept of Pharmaceutical Biosciences 
Uppsala University 
Box 591 
751 24 Uppsala Sweden 
phone: +46 18 4714105 
fax: +46 18 471 4003 
  
From: owner-nmus...@globomaxnm.com [mailto:owner-nmus...@globomaxnm.com] On 
Behalf Of nele.pl...@nycomed.com
Sent: Tuesday, April 14, 2009 5:09 PM
To: nmusers@globomaxnm.com
Subject: [NMusers] OMEGA BLOCK with mixture model? 
  

Dear all, 

I am trying to fit a PK model to oral data. In the data, we observed two 
things: First, CL seems to be negatively correlated with F1. Secondly, there 
seem to be two subpopulations in the exposure, let's say a large group with 
'normal' and a second group with high exposure. I would like to identify the 
subpopulations using a mixture model, but keep the correlation between CL and 
F1. Now I ran into problems when coding the $OMEGA BLOCK. 

I figured the block to be something like: 
$OMEGA BLOCK(3) 
0.1  ;CL1 
0 FIX 0.1 ;CL2 
0.01 0.01 0.1 ;F1 

The error message that appears is: 
a covariance is zero, but the block is not a band matrix 

I assume that this means that I am not allowed to fix the correlation between 
the two clearance-omegas to zero. However, it would be unreasonable to allow a 
correlation, because the omegas belong to different subpopulations, so there 
can't be a correlation. On the other hand, I did not include subpopulations for 
F1, so how can I keep this correlation to both CL-subgroups? 

Any thoughts on this would be highly appreciated! 
Best wishes 
Nele 
______________________________________________________________

Dr. Nele Plock
Pharmacometrics -- Modeling and Simulation

Nycomed GmbH
Byk-Gulden-Str. 2
D-78467 Konstanz, Germany

Fon: (+49) 7531 / 84 -  4759
Fax: (+49) 7531 / 84 - 94759

mailto: nele.pl...@nycomed.com
http://www.nycomed.com

County Court: Freiburg, Commercial Register HRB 701257
Chairman Supervisory Board: Charles Depasse
Management Board: Dr. Barthold Piening, Gilbert Rademacher, Dr. Anders Ullman 
  
  
  
  
  
---------------------------------------------------------------------- 
Proprietary or confidential information belonging to Nycomed Group may 
be contained in this message. If you are not the addressee indicated 
in this message, please do not copy or deliver this message to anyone. 
In such case, please destroy this message and notify the sender by 
reply e-mail. Please advise the sender immediately if you or your 
employer do not consent to Internet e-mail for messages of this kind. 
Opinions, conclusions and other information in this message that 
pertain to the sender's employer and its products and services 
represent the opinion of the sender and do not necessarily represent 
or reflect the views and opinions of the employer. 
---------------------------------------------------------------------- 

 
 
 
 
 
----------------------------------------------------------------------
Proprietary or confidential information belonging to Nycomed Group may
be contained in this message. If you are not the addressee indicated
in this message, please do not copy or deliver this message to anyone.
In such case, please destroy this message and notify the sender by
reply e-mail. Please advise the sender immediately if you or your
employer do not consent to Internet e-mail for messages of this kind.
Opinions, conclusions and other information in this message that
pertain to the sender's employer and its products and services
represent the opinion of the sender and do not necessarily represent
or reflect the views and opinions of the employer.
----------------------------------------------------------------------

Reply via email to